Di Nisio M, Squizzato A, Rutjes A W S, Büller H R, Zwinderman A H, Bossuyt P M M
Department of Medicine and Aging, School of Medicine, and Aging Research Centre, Ce.S.I., Gabriele D'Annunzio University Foundation, Chieti-Pescara, Italy.
J Thromb Haemost. 2007 Feb;5(2):296-304. doi: 10.1111/j.1538-7836.2007.02328.x. Epub 2006 Nov 28.
The reported diagnostic accuracy of the D-dimer test for exclusion of deep vein thrombosis (DVT) and pulmonary embolism (PE) varies. It is unknown to what extent this is due to differences in study design or patient groups, or to genuine differences between D-dimer assays.
Studies evaluating the diagnostic accuracy of the D-dimer test in the diagnosis of venous thromboembolism were systematically searched for in the MEDLINE and EMBASE databases up to March 2005. Reference lists of all included studies and of reviews related to the topic of the present meta-analysis were manually searched for other additional potentially eligible studies. Two reviewers independently extracted study characteristics using standardized forms.
In total, 217 D-dimer test evaluations for DVT and 111 for PE were analyzed. Several study design characteristics were associated with systematic differences in diagnostic accuracy. After adjustment for these features, the sensitivities of the D-dimer enzyme-linked immunofluorescence assay (ELFA) (DVT 96%; PE 97%), microplate enzyme-linked immunosorbent assay (ELISA) (DVT 94%; PE 95%), and latex quantitative assay (DVT 93%; PE 95%) were superior to those of the whole-blood D-dimer assay (DVT 83%; PE 87%), latex semiquantitative assay (DVT 85%; PE 88%) and latex qualitative assay (DVT 69%; PE 75%). The latex qualitative and whole-blood D-dimer assays had the highest specificities (DVT 99%, 71%; PE 99%, 69%).
Compared to other D-dimer assays, the ELFA, microplate ELISA and latex quantitative assays have higher sensitivity but lower specificity, resulting in a more confident exclusion of the disease at the expense of more additional imaging testing. These conclusions are based on the most up-to-date and extensive systematic review of the topic area, including 184 articles, with 328 D-dimer test evaluations.
D - 二聚体检测用于排除深静脉血栓形成(DVT)和肺栓塞(PE)的诊断准确性报道不一。目前尚不清楚这在多大程度上是由于研究设计或患者群体的差异,还是由于D - 二聚体检测方法之间的真正差异。
截至2005年3月,在MEDLINE和EMBASE数据库中系统检索评估D - 二聚体检测在静脉血栓栓塞症诊断中诊断准确性的研究。人工检索所有纳入研究的参考文献列表以及与本荟萃分析主题相关的综述,以查找其他可能符合条件的研究。两名审阅者使用标准化表格独立提取研究特征。
总共分析了217项针对DVT的D - 二聚体检测评估和111项针对PE的评估。多项研究设计特征与诊断准确性的系统差异相关。在对这些特征进行调整后,D - 二聚体酶联免疫荧光测定法(ELFA)(DVT为96%;PE为97%)、微孔酶联免疫吸附测定法(ELISA)(DVT为94%;PE为95%)和乳胶定量测定法(DVT为93%;PE为95%)的敏感性高于全血D - 二聚体测定法(DVT为83%;PE为87%)、乳胶半定量测定法(DVT为85%;PE为88%)和乳胶定性测定法(DVT为69%;PE为75%)。乳胶定性和全血D - 二聚体测定法具有最高的特异性(DVT为99%,71%;PE为99%,69%)。
与其他D - 二聚体检测方法相比,ELFA、微孔ELISA和乳胶定量测定法具有更高的敏感性,但特异性较低,这导致在排除疾病时更有信心,但代价是需要更多的额外影像学检查。这些结论基于对该主题领域最新且广泛的系统综述,包括184篇文章,共328项D - 二聚体检测评估。